vs
Ryman Hospitality Properties, Inc.（RHP）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Ryman Hospitality Properties, Inc.的季度营收约是Royalty Pharma plc的1.2倍（$737.8M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 10.1%，领先24.3%），Ryman Hospitality Properties, Inc.同比增速更快（13.9% vs 4.8%），过去两年Ryman Hospitality Properties, Inc.的营收复合增速更高（18.2% vs 4.6%）
莱曼酒店地产是一家主营酒店、度假村、娱乐及媒体业务的企业，得名于旗下位于田纳西州纳什维尔的国家历史地标莱曼礼堂。公司历史可追溯至曾为俄克拉荷马出版公司子公司时期，1983年收购WSM公司后奠定现代业务基础，同时将知名演出IP大奥普里等核心资产纳入麾下。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
RHP vs RPRX — 直观对比
营收规模更大
RHP
是对方的1.2倍
$622.0M
营收增速更快
RHP
高出9.1%
4.8%
净利率更高
RPRX
高出24.3%
10.1%
两年增速更快
RHP
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $737.8M | $622.0M |
| 净利润 | $74.5M | $214.2M |
| 毛利率 | 41.4% | — |
| 营业利润率 | 19.4% | 62.4% |
| 净利率 | 10.1% | 34.4% |
| 营收同比 | 13.9% | 4.8% |
| 净利润同比 | 3.0% | 2.9% |
| 每股收益（稀释后） | $1.12 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RHPRPRX
| Q4 25 | $737.8M | $622.0M | ||
| Q3 25 | $592.5M | $609.3M | ||
| Q2 25 | $659.5M | $578.7M | ||
| Q1 25 | $587.3M | $568.2M | ||
| Q4 24 | $647.6M | $593.6M | ||
| Q3 24 | $550.0M | $564.7M | ||
| Q2 24 | $613.3M | $537.3M | ||
| Q1 24 | $528.3M | $568.0M |
净利润RHPRPRX
| Q4 25 | $74.5M | $214.2M | ||
| Q3 25 | $34.9M | $288.2M | ||
| Q2 25 | $71.8M | $30.2M | ||
| Q1 25 | $63.0M | $238.3M | ||
| Q4 24 | $72.3M | $208.2M | ||
| Q3 24 | $59.0M | $544.0M | ||
| Q2 24 | $100.8M | $102.0M | ||
| Q1 24 | $42.8M | $4.8M |
毛利率RHPRPRX
| Q4 25 | 41.4% | — | ||
| Q3 25 | 40.9% | — | ||
| Q2 25 | 49.7% | — | ||
| Q1 25 | 44.4% | — | ||
| Q4 24 | 40.4% | — | ||
| Q3 24 | 43.1% | — | ||
| Q2 24 | 48.4% | — | ||
| Q1 24 | 41.5% | — |
营业利润率RHPRPRX
| Q4 25 | 19.4% | 62.4% | ||
| Q3 25 | 15.0% | 70.1% | ||
| Q2 25 | 21.1% | 36.3% | ||
| Q1 25 | 19.8% | 94.0% | ||
| Q4 24 | 18.6% | 60.9% | ||
| Q3 24 | 19.3% | — | ||
| Q2 24 | 27.4% | 50.2% | ||
| Q1 24 | 18.2% | -13.0% |
净利率RHPRPRX
| Q4 25 | 10.1% | 34.4% | ||
| Q3 25 | 5.9% | 47.3% | ||
| Q2 25 | 10.9% | 5.2% | ||
| Q1 25 | 10.7% | 41.9% | ||
| Q4 24 | 11.2% | 35.1% | ||
| Q3 24 | 10.7% | 96.3% | ||
| Q2 24 | 16.4% | 19.0% | ||
| Q1 24 | 8.1% | 0.8% |
每股收益（稀释后）RHPRPRX
| Q4 25 | $1.12 | $0.49 | ||
| Q3 25 | $0.53 | $0.67 | ||
| Q2 25 | $1.12 | $0.07 | ||
| Q1 25 | $1.00 | $0.55 | ||
| Q4 24 | $1.12 | $0.46 | ||
| Q3 24 | $0.94 | $1.21 | ||
| Q2 24 | $1.65 | $0.23 | ||
| Q1 24 | $0.67 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $471.4M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $750.2M | $9.7B |
| 总资产 | $6.2B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资RHPRPRX
| Q4 25 | $471.4M | $618.7M | ||
| Q3 25 | $483.3M | $938.9M | ||
| Q2 25 | $420.6M | $631.9M | ||
| Q1 25 | $413.9M | $1.1B | ||
| Q4 24 | $477.7M | $929.0M | ||
| Q3 24 | $534.9M | $950.1M | ||
| Q2 24 | $498.4M | $1.8B | ||
| Q1 24 | $465.3M | $843.0M |
总债务RHPRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益RHPRPRX
| Q4 25 | $750.2M | $9.7B | ||
| Q3 25 | $758.5M | $9.6B | ||
| Q2 25 | $800.4M | $9.5B | ||
| Q1 25 | $531.5M | $9.8B | ||
| Q4 24 | $549.0M | $10.3B | ||
| Q3 24 | $551.9M | $10.3B | ||
| Q2 24 | $562.6M | $9.8B | ||
| Q1 24 | $529.9M | $9.9B |
总资产RHPRPRX
| Q4 25 | $6.2B | $19.6B | ||
| Q3 25 | $6.2B | $19.3B | ||
| Q2 25 | $6.1B | $18.3B | ||
| Q1 25 | $5.2B | $17.6B | ||
| Q4 24 | $5.2B | $18.2B | ||
| Q3 24 | $5.2B | $18.0B | ||
| Q2 24 | $5.1B | $17.7B | ||
| Q1 24 | $5.1B | $16.1B |
负债/权益比RHPRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $164.7M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $58.5M | — |
| 自由现金流率自由现金流/营收 | 7.9% | — |
| 资本支出强度资本支出/营收 | 14.4% | — |
| 现金转化率经营现金流/净利润 | 2.21× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $232.4M | — |
8季度趋势，按日历期对齐
经营现金流RHPRPRX
| Q4 25 | $164.7M | $827.1M | ||
| Q3 25 | $205.2M | $702.6M | ||
| Q2 25 | $122.5M | $364.0M | ||
| Q1 25 | $98.2M | $596.1M | ||
| Q4 24 | $166.6M | $742.5M | ||
| Q3 24 | $218.1M | $703.6M | ||
| Q2 24 | $184.3M | $658.2M | ||
| Q1 24 | $7.5M | $664.6M |
自由现金流RHPRPRX
| Q4 25 | $58.5M | — | ||
| Q3 25 | $135.4M | — | ||
| Q2 25 | $53.0M | — | ||
| Q1 25 | $-14.5M | — | ||
| Q4 24 | $76.0M | — | ||
| Q3 24 | $85.7M | — | ||
| Q2 24 | $78.8M | — | ||
| Q1 24 | $-72.0M | — |
自由现金流率RHPRPRX
| Q4 25 | 7.9% | — | ||
| Q3 25 | 22.9% | — | ||
| Q2 25 | 8.0% | — | ||
| Q1 25 | -2.5% | — | ||
| Q4 24 | 11.7% | — | ||
| Q3 24 | 15.6% | — | ||
| Q2 24 | 12.9% | — | ||
| Q1 24 | -13.6% | — |
资本支出强度RHPRPRX
| Q4 25 | 14.4% | — | ||
| Q3 25 | 11.8% | — | ||
| Q2 25 | 10.5% | — | ||
| Q1 25 | 19.2% | — | ||
| Q4 24 | 14.0% | — | ||
| Q3 24 | 24.1% | — | ||
| Q2 24 | 17.2% | — | ||
| Q1 24 | 15.0% | — |
现金转化率RHPRPRX
| Q4 25 | 2.21× | 3.86× | ||
| Q3 25 | 5.88× | 2.44× | ||
| Q2 25 | 1.71× | 12.06× | ||
| Q1 25 | 1.56× | 2.50× | ||
| Q4 24 | 2.30× | 3.57× | ||
| Q3 24 | 3.70× | 1.29× | ||
| Q2 24 | 1.83× | 6.45× | ||
| Q1 24 | 0.17× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RHP
| Hotel Other | $157.7M | 21% |
| Gaylord Opryland | $147.4M | 20% |
| Hotel Transient Rooms | $93.6M | 13% |
| Hotel Food And Beverage Outlets | $92.2M | 12% |
| Gaylord Palms | $88.2M | 12% |
| Jw Marriott Hill Country | $53.7M | 7% |
| Entertainment Admissions And Ticketing | $43.1M | 6% |
| Entertainment Food And Beverage | $38.1M | 5% |
| Entertainment Retail And Other | $28.3M | 4% |
| Ac Hotel | $2.4M | 0% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
